APA (7th ed.) Citation

SP, H., W, V., S, M., B, L., Y, W., T, M., . . . AX, Z. (2021). IMbrave 151: A randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer. Therapeutic advances in medical oncology, 13, 17588359211036544. https://doi.org/10.1177/17588359211036544

Chicago Style (17th ed.) Citation

SP, Hack, Verret W, Mulla S, Liu B, Wang Y, Macarulla T, Ren Z, El-Khoueiry AB, and Zhu AX. "IMbrave 151: A Randomized Phase II Trial of Atezolizumab Combined with Bevacizumab and Chemotherapy in Patients with Advanced Biliary Tract Cancer." Therapeutic Advances in Medical Oncology 13 (2021): 17588359211036544. https://doi.org/10.1177/17588359211036544.

MLA (9th ed.) Citation

SP, Hack, et al. "IMbrave 151: A Randomized Phase II Trial of Atezolizumab Combined with Bevacizumab and Chemotherapy in Patients with Advanced Biliary Tract Cancer." Therapeutic Advances in Medical Oncology, vol. 13, 2021, p. 17588359211036544, https://doi.org/10.1177/17588359211036544.